Spectral AI, Inc. (MDAI)
1.625
+0.02
(+0.93%)
USD |
NASDAQ |
Aug 27, 16:00
1.66
+0.04
(+2.15%)
After-Hours: 20:00
Spectral AI Gross Profit Margin (Quarterly) : 31.58% for June 30, 2026
Gross Profit Margin (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Gross Profit Margin (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | 31.58% |
| March 31, 2026 | 50.79% |
| December 31, 2025 | 39.78% |
| September 30, 2025 | 42.75% |
| June 30, 2025 | 45.21% |
| March 31, 2025 | 47.23% |
| December 31, 2024 | 44.03% |
| September 30, 2024 | 44.87% |
| Date | Value |
|---|---|
| June 30, 2024 | 44.32% |
| March 31, 2024 | 46.55% |
| December 31, 2023 | 46.08% |
| September 30, 2023 | 42.79% |
| June 30, 2023 | 42.13% |
| March 31, 2023 | 42.95% |
| December 31, 2022 | 41.14% |
| September 30, 2022 | 45.85% |
Gross Profit Margin Definition
Gross Profit Margin is calculated using Gross Profit/Revenue. This metric measures the overall efficiency of a company in being able to turn revenue into gross profit and doing this by keeping cost of goods sold low. An analyst looking at gross profit margin might look for a higher gross profit margin relative to other comparable companies as well as a gross profit margin that is growing.
Gross Profit Margin (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Gross Profit Margin (Quarterly) Benchmarks
| Co-Diagnostics, Inc. | -48.77% |
| Fractyl Health, Inc. | -- |
| NovelStem International Corp. | -- |
| IGC Pharma, Inc. | 2.64% |
| Omnicell, Inc. | 48.98% |
Gross Profit Margin (Quarterly) Related Metrics
| Return on Assets | -58.40% |
| Return on Invested Capital | -450.3% |
| Profit Margin (Quarterly) | -118.5% |
| Operating Margin (Quarterly) | -122.7% |
| Return on Net Operating Assets | -244.3% |